×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AKYA – akoya biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AKYA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/5
01:00 pm
akya
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - OPTN, SLRN, AKYA, SHYF
Neutral
Report
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - OPTN, SLRN, AKYA, SHYF
4/2
08:00 am
akya
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
Low
Report
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
3/25
10:47 am
akya
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "equal weight" rating re-affirmed by analysts at Stephens. They now have a $1.80 price target on the stock, down previously from $3.50.
Medium
Report
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "equal weight" rating re-affirmed by analysts at Stephens. They now have a $1.80 price target on the stock, down previously from $3.50.
3/18
09:44 am
akya
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $3.50 price target on the stock.
High
Report
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $3.50 price target on the stock.
3/17
04:00 pm
akya
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
Medium
Report
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
3/10
12:06 pm
akya
Akoya Biosciences, Inc. (NASDAQ: AKYA) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating.
Low
Report
Akoya Biosciences, Inc. (NASDAQ: AKYA) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating.
2/24
05:01 am
akya
Nuclera Appoints Seth Benson as Chief Financial Officer [Yahoo! Finance]
High
Report
Nuclera Appoints Seth Benson as Chief Financial Officer [Yahoo! Finance]
2/5
08:00 am
akya
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
Medium
Report
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/4
08:31 am
akya
Form 425 Akoya Biosciences, Inc. Filed by: Akoya Biosciences, Inc.
Medium
Report
Form 425 Akoya Biosciences, Inc. Filed by: Akoya Biosciences, Inc.
4/4
08:31 am
akya
Form 8-K Akoya Biosciences, Inc. For: Apr 02
Medium
Report
Form 8-K Akoya Biosciences, Inc. For: Apr 02
4/4
06:12 am
akya
Form 425 Akoya Biosciences, Inc. Filed by: Quanterix Corp
Medium
Report
Form 425 Akoya Biosciences, Inc. Filed by: Quanterix Corp
4/3
05:15 pm
akya
Form 4 Akoya Biosciences, Inc. For: Apr 01 Filed by: Ek John Frederick
Medium
Report
Form 4 Akoya Biosciences, Inc. For: Apr 01 Filed by: Ek John Frederick
3/25
06:34 pm
akya
Form 4 Akoya Biosciences, Inc. For: Mar 23 Filed by: McKelligon Brian
Medium
Report
Form 4 Akoya Biosciences, Inc. For: Mar 23 Filed by: McKelligon Brian
3/25
06:33 pm
akya
Form 4 Akoya Biosciences, Inc. For: Mar 23 Filed by: Ramachandran Niro Ph.D
Medium
Report
Form 4 Akoya Biosciences, Inc. For: Mar 23 Filed by: Ramachandran Niro Ph.D
3/18
12:36 pm
akya
Form 425 Akoya Biosciences, Inc. Filed by: Quanterix Corp
Medium
Report
Form 425 Akoya Biosciences, Inc. Filed by: Quanterix Corp
3/17
04:26 pm
akya
Form 425 Akoya Biosciences, Inc. Filed by: Quanterix Corp
Medium
Report
Form 425 Akoya Biosciences, Inc. Filed by: Quanterix Corp
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: